{"title":"Severe Thrombocytopenia after PCI: Think GP IIb/IIIa Receptor Antagonist Induced rather than Heparin-induced Thrombocytopenia","authors":"Usnish Adhikari, Krishna Kumar Mohanan Nair","doi":"10.1177/26324636231213452","DOIUrl":null,"url":null,"abstract":"Acute thrombocytopenia in Acute Coronary Syndrome patients may pose a diagnostic challenge due to multifactorial etiologies. It is a recognized, but rare complication of treatment with glycoprotein IIb/IIIa receptor antagonists, which are commonly used in the management of Acute Coronary Syndrome. Diagnosis is made after ruling out other common causes, one of them being Heparin-induced thrombocytopenia. Management includes discontinuation of GPRA & in severe cases might require steroids. We present a case of a 38-year-old gentleman with acute inferior wall MI, who developed glycoprotein IIb/IIIa receptor antagonists-induced acute symptomatic thrombocytopenia.","PeriodicalId":429933,"journal":{"name":"Indian Journal of Clinical Cardiology","volume":"48 1","pages":"283 - 286"},"PeriodicalIF":0.0000,"publicationDate":"2023-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Clinical Cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/26324636231213452","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Acute thrombocytopenia in Acute Coronary Syndrome patients may pose a diagnostic challenge due to multifactorial etiologies. It is a recognized, but rare complication of treatment with glycoprotein IIb/IIIa receptor antagonists, which are commonly used in the management of Acute Coronary Syndrome. Diagnosis is made after ruling out other common causes, one of them being Heparin-induced thrombocytopenia. Management includes discontinuation of GPRA & in severe cases might require steroids. We present a case of a 38-year-old gentleman with acute inferior wall MI, who developed glycoprotein IIb/IIIa receptor antagonists-induced acute symptomatic thrombocytopenia.